Your browser doesn't support javascript.
Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products.
Manian, Deepti Vellaichamy; Jensen, Chelsee; Theel, Elitza S; Mills, John R; Joshi, Avni.
  • Manian DV; Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Jensen C; Mayo Clinic, Rochester, Minnesota.
  • Theel ES; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Mills JR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Joshi A; Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: Joshi.avni@mayo.edu.
Ann Allergy Asthma Immunol ; 126(2): 206-207, 2021 02.
Article in English | MEDLINE | ID: covidwho-987014

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin G / Common Variable Immunodeficiency / COVID-19 Serological Testing / SARS-CoV-2 / Antibodies, Viral Type of study: Case report / Diagnostic study Limits: Female / Humans / Middle aged Language: English Journal: Ann Allergy Asthma Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin G / Common Variable Immunodeficiency / COVID-19 Serological Testing / SARS-CoV-2 / Antibodies, Viral Type of study: Case report / Diagnostic study Limits: Female / Humans / Middle aged Language: English Journal: Ann Allergy Asthma Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article